Ir al contenido principal

SIL1 nucleotide exchange factor

El SIL1 gene provides instructions for producing a protein located in a cell structure called the endoplasmic reticulum. Among its many functions, the endoplasmic reticulum folds and modifies newly formed proteins so they have the correct 3-dimensional shape. The SIL1 protein works with BiP, a protein that helps fold newly produced proteins into the proper shape and refold damaged proteins. To start this process, BiP attaches (binds) to a molecule called adenosine triphosphate (ATP). When BiP folds a protein, the ATP is converted to a similar molecule called adenosine diphosphate (ADP). Then the SIL1 protein releases ADP from BiP so that it can bind to another molecule of ATP and start the protein folding process again. Because of its role in helping BiP exchange ADP for ATP, the SIL1 protein is called a nucleotide exchange factor.

Selecciones de videos para Genes
Biblioteca de videos

Normal function

El SIL1 gene provides instructions for producing a protein located in a cell structure called the endoplasmic reticulum. Among its many functions, the endoplasmic reticulum folds and modifies newly formed proteins so they have the correct 3-dimensional shape. The SIL1 protein works with BiP, a protein that helps fold newly produced proteins into the proper shape and refold damaged proteins. To start this process, BiP attaches (binds) to a molecule called adenosine triphosphate (ATP). When BiP folds a protein, the ATP is converted to a similar molecule called adenosine diphosphate (ADP). Then the SIL1 protein releases ADP from BiP so that it can bind to another molecule of ATP and start the protein folding process again. Because of its role in helping BiP exchange ADP for ATP, the SIL1 protein is called a nucleotide exchange factor.

Conditions referring to this gene or chromosome

Otros nombres

BAP

BiP-associated protein

MSS

SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae)

SIL1 protein

SIL1_HUMAN

ULG5

Related patient information and medicines

Cáncer de garganta

Patient information leaflet

Cáncer de garganta

(The throat is usually sprayed with a local anaesthetic before use of a nasal endoscope, so that the procedure i... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their.

Cáncer de boca

Patient information leaflet

Cáncer de boca

Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if you have a lesion in your mouth (such as a sore, an ulcer or a lump) which has not healed for 3 wee... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or.

Causas del cáncer

Patient information leaflet

Causas del cáncer

Seguro risk factors are known to increase the chance that one or more of your cells will become abnormal and lead to cancer. How does cancer start. Different parts of the body such as organs, bones... Most cells have a centre called a nucleus. The nucleus in each cell contains thousands of genes which are made up from a chemical called DNA. The.

Leucemia linfoblástica aguda

Patient information leaflet

Leucemia linfoblástica aguda

Análisis de células y cromosomas Detailed tests are done on. These find out the exact type of cell that is abnormal - for example, if the abnormal cells are immature B lymphocytes or immature T lymphocytes. The chromosomes within the cells are checked for certain changes. Chromosomes are the parts in the cell which contain DNA - the genetic makeup of.

Mieloma

Patient information leaflet

Mieloma

See Further Reading and References below. Dr Krishna Vakharia, 27th June 2023 Daratumumab con bortezomib and dexamethasone for previously treated multiple myeloma NICE has recommended the above treatment regime for those people who have had one treatment already with lenalidomide or if the lenalidomide cannot be used again as a second line.

Oclusión de la vena retiniana

Patient information leaflet

Oclusión de la vena retiniana

Condiciones cuál increase the risk of retinal vein occlusion include. High cholesterol/high lipid levels. Raised pressure in the eye (glaucoma). Diabetes. Smoking. Conditions which 'thicken' the blood. What are the symptoms of retinal vein occlusion. If you have retinal vein occlusion, you will usually notice a decrease in your vision in one eye..

Lecturas adicionales y referencias

Historial del artículo

La información en esta página está escrita y revisada por pares por clínicos calificados.
  • 18 Aug 2020 | Última versión
  • 1 Sept 2008 | Publicado originalmente

Únete a la conversación

Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.

Aviso legal: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia en línea, tratamientos y servicios de salud

Acceso sencillo a tratamientos y servicios de salud confiables en línea.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Suscríbete al boletín de Patient

Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.

Por favor, introduce una dirección de correo electrónico válida

Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.